AI Analysis AI Analysis of BIOYF AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BIOYF to Watchlist?
Some Reasons Why To Add BIOYF:
  • Beat earnings estimates in 3 of the last 4 quarters
  • Healthy interest coverage ratio of 170.1x
  • High gross margin of 74.1%
PDF

Red day on Friday for BioSyent Inc.
(Updated on Jul 10, 2026)

Buy or Hold candidate since Jul 06, 2026 Loss -0.29%

The BioSyent Inc. stock price fell by -0.619% on the last day (Friday, 10th Jul 2026) from $10.34 to $10.28. During the last trading day the stock fluctuated 0.195% from a day low at $10.28 to a day high of $10.30. The price has fallen in 4 of the last 10 days but is still up by 4.58% over the past 2 weeks. Volume has increased on the last day by 2 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 thousand shares were bought and sold for approximately $16.45 thousand.

The stock lies the upper part of a falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $10.33 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -8.80% during the next 3 months and, with a 90% probability hold a price between $8.72 and $9.42 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

BIOYF Signals & Forecast

The BioSyent Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $10.27 and $10.06. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 23, 2026, and so far it has risen 5.37%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. BioSyent Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for BioSyent Inc. stock

BioSyent Inc. finds support from accumulated volume at $10.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.0200 between high and low, or 0.195%. For the last week the stock has had daily average volatility of 0.147%.

Our recommended stop-loss: $9.89 (-3.84%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 12 days ago.)

Trading Expectations (BIOYF) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect BioSyent Inc. to open at $10.29, and during the day (based on 14 day Average True Range), to move between $10.23 and $10.33, which gives a possible trading interval of +/-$0.107 (+/-1.04%) up or down from last closing price. If BioSyent Inc. takes out the full calculated possible swing range there will be an estimated 1.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $10.20 (0.78%) than the resistance at $10.41 (1.29%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is BioSyent Inc. stock A Buy?

BioSyent Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $10.29 ( 0.0649%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BIOYF Performance

Trading levels for BIOYF

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 10.31 0.259%
R2 10.30 0.185%
R1 10.29 0.139%
Price 10.28
S1 10.28 -0.0095%
S2 10.27 -0.0554%
S3 10.27 -0.130%

Accumulated Volume Support & Resistance Levels

Level Price
R3 10.70 4.09%
R2 10.69 3.99%
R1 10.41 1.29%
Price 10.28
S1 10.20 -0.778%
S2 9.90 -3.70%
S3 9.89 -3.79%

BIOYF Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 29, 2026 May 29, 2026 Jun 15, 2026 $0.0401 0.382%
2 Jan 29, 2026 Feb 27, 2026 Mar 13, 2026 $0.0406 0.378%
3 Nov 28, 2025 Nov 28, 2025 Dec 15, 2025 $0.0355 0.442%
4 Aug 29, 2025 Aug 29, 2025 Sep 15, 2025 $0.0359 0.408%
5 May 30, 2025 May 30, 2025 Jun 13, 2025 $0.0358 0.424%

FAQ

What is the symbol for BioSyent Inc. Stock and on which exchange is it traded?
The symbol for BioSyent Inc. is BIOYF and it is traded on the PINK (Pink Sheets).

Should I buy or sell BioSyent Inc. Stock?
BioSyent Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy BioSyent Inc. Stock?
BioSyent Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioSyent Inc. Stock.

What's the current price of BioSyent Inc. Stock?
As of the end of day on the Jul 10, 2026, the price of an BioSyent Inc. (BIOYF) share was $10.28.

What is the 52-week high and low for BioSyent Inc. Stock?
The 52-week high for BioSyent Inc. Stock is $12.00 and the 52-week low is $7.63.

What is the market capitalization of BioSyent Inc. Stock?
As of the Jul 10, 2026, the market capitalization of BioSyent Inc. is 117.586M.

When is the next earnings date for BioSyent Inc.?
The upcoming earnings date for BioSyent Inc. is Aug 25, 2026.
Click to get the best stock tips daily for free!
ABOUT BIOSYENT INC.
BioSyent
BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX 150, an oral hematinic; FeraMAX Powder, a water soluble oral iron supplement, which helps the body form red blood cells; and FeraMAX Pd Therapeutic 150 for the prevention and treatment of iron deficiency anemia. It also offers Cathejell, a ...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE